Many WT1 variants that are identified in patients with Wilms tumor only are truncating variants located outside the hotspot region, in contrast to the variants that were identified earlier in patients with Denys-Drash syndrome or severe, early-onset glomerulopathy. This evidence concerns the gene WT1 and Wilms tumor.